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ABSTRACT
Background and objectives: Rotavirus (RV) is the main etiological agent of diarrhea in childhood; its 
laboratory diagnosis is crucial to guide the clinical management and prevention of its spread. RV im-
munization was introduced in Brazilian 6-month-old children in 2006. The present study was aimed 
to evaluate three methodologies used for human RV detection in stool samples obtained from patients 
hospitalized due to gastroenteritis in a teaching hospital and report the impact of RV immunization 
in hospitalization by diarrhea. Methods: 293 stool samples collected in the 2001-2008 period were ana-
lyzed by enzyme immunoassay (EIA), latex agglutination (LA) and polyacrylamide gel electrophoresis 
(PAGE). Results: Rotavirus was detected in 34.8% of samples by LA assay, 28.3% of samples by EIA 
assay and in 25.6% of samples by PAGE assay. Considering the PAGE method as gold standard, the 
sensitivity, specificity and accuracy of EIA were 94.6%, 94.4% and 94.5%, and to LA were 82.6%, 81.6% 
and 81.9%, respectively. Conclusions: These results indicate that antigen detection by EIA is a rapid, 
sensitive and specific method, and could be used in large-scale applications for screening stool samples 
suspected of RV infection. This study showed decreased incidence of RV infection in hospitalized chil-
dren prior to the implementation of the national immunization program against RV.
Keywords: rotavirus; diarrhea; immunoenzyme techniques; latex fixation tests; electrophoresis; 
polyacrylamide gel.
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INTRODUCTION
Diarrhea is a leading cause of deaths in chil-
dren despite the decline in mortality observed 
over the past few years.1,2 Rotavirus (RV) is the 
most important etiological agent of diarrhea in 
children under five years old, and accounts for 
111 million episodes of gastroenteritis in the 
world, and for approximately 611,000 deaths 
annually, mainly in developing countries.2 
In Brazil, several studies were conducted to 
demonstrate the importance of RV in children 
morbidity and mortality.3-10 
The rotavirus belongs to the Reoviridae 
family, exhibits icosahedral symmetry, it is not 
enveloped and was first identified by electron 
microscopy by Bishop et al.11 The viral parti-
cle consists of three layers of protein and the 
viral genome consists of 11 segments of dou-
ble-stranded RNA (dsRNA), which encode six 
structural proteins, VP1-4, VP6 and VP7 and 
six non-structural proteins, NSP1-6.12,13 The 
VP6 protein, located in the inner capsid of 
the virus contains the antigenic determinants, 
which allow their classification into seven sero-
groups of A to G, with group A being the most 
common agent of childhood diarrhea.2,6,13,14 
RV infection can range from mild diarrhea, 
with limited duration, to a severe case, with fe-
ver, vomiting and dehydration.15-17
Laboratory diagnosis of rotavirus infection 
is usually performed by antigen detection, using 
enzyme immunoassay15 or latex agglutination 
(LA) techniques, which have a sensitivity and 
specificity above 90%. Molecular techniques 
such as polyacrylamide gel electrophoresis 
(PAGE) and reverse transcription-polymerase 
chain reaction (RT-PCR) are used to determine 
the RNA migration patterns and virus geno-
typing, respectively.18-21
In 2006, the RV vaccine was introduced 
by the Brazilian National Immunization Pro-
gram for children younger than six months. 
Since then, the impact of this immunization 
has been analyzed by monitoring the decrease 
of children hospitalization due to gastroen-
teritis and by laboratorial surveillance based 
on viral antigen tests results.22 The virology 
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laboratory of Hospital de Clínicas - Universidade Federal 
do Paraná (HC-UFPR), a teaching hospital, has detected 
this virus in children hospitalized due to gastroenteritis. 
Screening by antigen detection using EIA or LA methods 
was carried out, followed by PAGE techniques to perform 
viral profile analysis. Positive samples for the detection of 
viral antigens are notified and sent to reference laboratories 
for genetic characterization. The results of these laborato-
ry screening tests and the impact of the immunization on 
the incidence of RV infection in children admitted to the 
 Hospital de Clínicas - UFPR are presented in this study.
MATERIALS AND METHODS
Stool samples from patients with acute gastroenteritis 
admitted to the HC-UFPR from April 2001 to December 
2008 were analyzed using the LA and EIA for antigen de-
tection, and PAGE for RNA detection methods.
The stool samples were collected in plastic vials without 
preservatives and sent to the virology laboratory immedi-
ately a! er collection. The samples were then processed or 
stored at -20ºC for as long as 24 hours before processing.
EIA was performed using Rotascreen II kit® (Rotascreen 
II-Microgen-Bioproducts- Camberley, U.K.) or EIARA 
kit (Immunoassay for rotavirus and adenovirus-Bioman-
guinhos, RJ, Brazil). Latex agglutination was carried out 
using Virotect kit® (Omega Diagnostics, Scotland, United 
Kingdom) or Rotascreen® Kit (Rotascreen-Microgen-Bio-
products, Camberley, U.K). Both methods were performed 
according to the manufacturer’s instructions. All tests kits 
cover all the requirements of the Brazilian Sanitary Sur-
veillance Agency (ANVISA) for use in laboratory diagno-
sis. Furthermore, they were validated by the local virology 
laboratory, where the analysis of a previously characterized 
group of samples was carried out. 
PAGE was standardized using the method previously 
reported by Boom et al.23 with some modifications for the 
extraction of viral RNA and separation of genomic seg-
ments.24 The RNA was loaded onto a polyacrylamide dis-
continuous gel (7.5% - separator and 3.5% - concentrator) 
for 2 hours at 100 V. The gel wa   s stained with silver nitrate 
using the method of Herring et al.25 RNA extracted from 
simian RV (SA11) was used as positive control on PAGE 
analysis.
Statistical analysis
Descriptive analysis was performed for all variables. Data 
were stored and analyzed using JMP So! ware Version 5.2.1. 
Sensitivity, specificity, accuracy, likelihood ratios (LRs), 
positive and negative predictive values were calculated us-
ing binomial exact methods. According to these calcula-
tions, a specimen was considered to contain the rotavirus 
when it was positive by PAGE (gold standard). Agreement 
between the assays was evaluated using Kappa coe! cient. 
Kappa values above 0.75 indicate strong agreement; values 
between 0.40 and 0.75 represent fair to good agreement 
and values below 0.40 reflect poor agreement. Correla-
tion between EIA, LA and PAGE was analyzed using the 
Spearman correlation coe! cient. The di! erences between 
groups were analyzed using Chi-square test or Fisher’s 
exact test, as appropriate. All tests were over two-tails. 
A p-value < 0.05 was considered statistically significant.
Ethics
The procedures involving the use of the bank of clinical 
samples from the laboratory of virology for the detection of 
RV in human stool samples had the approval of the Com-
mittee on the Ethics of Research on Human Beings of the 
HC-UFPR, under registration number 4441.023/2002-04.
RESULTS
A total of 293 fecal samples collected from 286 children 
with acute gastroenteritis were analyzed. The rotavirus an-
tigen was detected in 34.8% (102/293) of the samples by LA, 
28.3% (83/293) by EIA and in 25.5% (75/293) by PAGE. 
Figure 1 shows the distribution of positive samples by 
the di! erent diagnostic tests and the total amount of samples 
collected each year. Overall, there was a good correlation 
between the tests, though not for all the years of the study. 
Significant di! erences between the results were observed in 
2007 when all samples were positive only by latex aggluti-
nation, characterizing false positive results. A decline in the 
number of patients positive for rotavirus has been observed 
since 2004, two years before the vaccine introduction. 
Compared to PAGE, EIA presented 94.6%, 94.4% and 
94.5% of sensitivity, specificity and accuracy, respectively. 
The positive predictive value was 85.5% and the negative 
predictive value was 98%. The sensitivity, specificity and 
accuracy of the LA test were respectively 82.6%, 81.6% and 
81.9%. The positive predictive value was 60.7% and the 
negative predictive value was 93.1%. Considering all 
the results obtained, the agreement beyond chance be-
tween the tests (Kappa measures) was 0.86 and 0.57 for 
Figure 1: Rotavirus positive results and number of samples 
studied, 2001-2008. 
PAGE, polyacrylamide gel electrophoresis; EIA, enzyme 
immunoassay; LA, latex agglutination.
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EIA and LA, respectively. The likelihood ratio values of EIA 
(LR+ and LR-) demonstrated that, unlike LA, test results were 
essential to help confirm diagnosis. There was no significant 
di! erence between PAGE and EIA (p = 0.51), in contrast to 
the comparison between PAGE and LA (p = 0.018). 
Figure 2 shows the contingency table obtained by com-
parison of the results of EIA and LA with PAGE results, 
and the summary of the operational characteristics of the 
tests of rotavirus antigen detection. 
DISCUSSION
Several decades after the rotavirus’ description, many 
studies have been carried out to compare detection tech-
niques.19,26-31 Currently, several commercial tests are avail-
able from those based on less laborious techniques that 
enable a quick diagnosis, e.g. antigen detection methods, 
to more complex tests such as the polymerase chain reac-
tion.32-34 
In this study, we evaluated di! erent antigen detection 
tests for establishing the diagnosis of rotavirus infection in 
stool samples from children with gastroenteritis. The preva-
lence of RV-associated diarrhea of 25.6% (75/293) was simi-
lar to that reported in Brazil35,36 and in other countries.37,38 
PAGE is an important tool to understand the epidemiol-
ogy of RV and it was chosen as the gold standard test due 
to its specificity and practicability and also, because it de-
tects non-A RV.39-41 However, its use as screening test is not 
recommended due to the need for technical training for its 
implementation and longer time of execution.42 Some posi-
tive results to antigen detection by EIA and LA were found, 
though with negative results by PAGE. It is important to 
mention that the antigen detection tests using PAGE were 
carried out at di! erent moments, and the samples were fro-
zen at -70ºC for di! erent periods, which may have a! ected 
PAGE results.
There was no significant di! erence between the EIA and 
PAGE methods. The positive and negative likelihood ratio 
showed that EIA positive and negative results can be used to 
confirm diagnosis of rotavirus infection. These results indi-
cate that EIA assay is as sensitive and specific as the PAGE 
method, and could be applied on a large scale from the 
screening of stool suspected of rotavirus diarrhea, having a 
good correlation with the disease.21,34,43,44
Agreement beyond chance the tests between LA and 
PAGE showed regular/good agreement, demonstrating low 
sensitivity for latex agglutination test, as shown in other 
studies.20,45-47 Regarding specificity, some authors report 
that, unlike our findings, they have found values above 90%, 
where the specificity obtained in this study was 81.9%.42,48 
In general, the results obtained by PAGE and EIA had 
strong agreement, unlike the findings for PAGE and LA. 
Recent reports show that the performance of commercially 
available latex agglutination tests compares favorably to 
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Figure 2: Rotavirus diagnosis. Contingency table and operational characteristics of antigen detection tests. 
PAGE, polyacrylamide gel electrophoresis; EIA, enzyme immunoassay.
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virus isolation and ELISA.49 Nevertheless, in this study, 
the variability observed in LA results for some years has 
strongly jeopardized its reliability as a screening test. Thus, 
it has not been possible to predict the occurrence (or non-
occurrence) of the disease based on LA results. Although 
this technique may be useful in certain situations, such as 
outbreaks of the disease, or in locations with lack of re-
sources for RV detection, because it is fast, practical and 
has low cost.31,50 
A di! erent distribution of positive samples was observed 
using this method in di! erent years, with a progressive 
decline in the number of samples investigated since 2004. 
A study to assess the impact of vaccination against rotavirus 
has been previously conducted by our institution. The num-
ber of outpatient appointments and hospital admissions for 
gastroenteritis before and a! er the implementation of the 
vaccine (2005 and 2007) was assessed. That study showed a 
reduction of 54.2% and 39.4% of medical appointments for 
children less than 12 months old and 12 to 60 months old re-
spectively. Furthermore, there was also a reduction of 43.9% 
and 33.3% of hospital admissions due to gastroenteritis in 
children less than 12 months old and 12 to 60 months old, 
respectively, considering vaccination coverage around 80% 
in the referred period.51 
The decline in the number of positive cases observed 
in this study, before vaccine implementation, can be ex-
plained by the improvement of sanitation conditions (ac-
cess of the poorest populations of the region to safe sani-
tation) and also by the success of public health policies 
based on the availability of primary care at health units 
and by the policy of the teaching hospital of referring se-
vere cases to tertiary care. 
Despite the fact that the vaccination program is be-
ing implemented on a continuous basis and its initial 
impact on the reduction of cases of rotavirus infection, 
we found that hospital admissions for severe cases of 
the infection persist in the tertiary hospital. This can be 
explained by the occurrence of the disease in patients 
with risk factors who did not respond to vaccine or were 
not vaccinated. Therefore, it is essential to proceed with 
laboratory diagnosis of this disease, as well as to moni-
tor viral genetic variability, which could influence the 
response to immunization.
RV vaccines have been introduced in Brazilian Immuni-
zation Calendar and the surveillance has been made by labo-
ratory diagnosis using antigen detection methods. It is im-
portant to assess the performance of these methods in order 
to know how these can influence the data obtained and to 
try to maintain a homogenous guidelines for laboratory tests 
in all public laboratories. Concerning the methodologies 
employed to diagnose RV, the results of this study stress the 
need for constant evaluations of the performance of RV de-
tection tests due to the great availability of kits in the market.
CONCLUSION
A few laboratories in Brazil perform tests to diagnose RV in-
fection, and there is not a standardization of what methods 
should be used. These results indicate that antigen detection 
by LA has higher sensitivity, but lower specificity than EIA, 
which is a rapid, sensitive and specific method, and could be 
used in large-scale for screening of stool samples suspected 
of RV infection. EIA would provide the most appropriate 
information to monitoring RV infection, and consequently 
yield the clearest baseline information to assess immuniza-
tion response. 
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